Multiple Endocrine Neoplasia Type 1 (MEN1) Phenocopy Due to a Cell Cycle Division 73 (CDC73) Variant
Open Access
- 26 September 2020
- journal article
- research article
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 4 (11), bvaa142
- https://doi.org/10.1210/jendso/bvaa142
Abstract
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterized by the combined occurrence of parathyroid tumors, pituitary adenomas, and pancreatic neuroendocrine neoplasms (PNENs). MEN1 is caused by germline MEN1 mutations in > 75% of patients, and the remaining 25% of patients may have mutations in unidentified genes or represent phenocopies with mutations in genes such as cell cycle division 73 (CDC73), the calcium sensing receptor (CASR), and cyclin-dependent kinase inhibitor 1B (CDKN1B), which are associated with the hyperparathyroidism-jaw tumor syndrome, familial hypocalciuric hypercalcemia type 1, and MEN4, respectively. Here, we report a heterozygous c.1138C>T (p.Leu380Phe) CDC73 germline variant in a clinically diagnosed MEN1 patient, based on combined occurrence of primary hyperparathyroidism, acromegaly, and a PNEN. Characterization of the PNEN confirmed it was a neuroendocrine neoplasm as it immuno-stained positively for chromogranin and glucagon. The rare variant p.Leu380Phe occurred in a highly conserved residue, and further analysis using RNA-Scope indicated that it was associated with a significant reduction in CDC73 expression in the PNEN. Previously, CDC73 mutations have been reported to be associated with tumors of the parathyroids, kidneys, uterus, and exocrine pancreas. Thus, our report of a patient with PNEN and somatotrophinoma who had a CDC73 variant, provides further evidence that CDC73 variants may result in a MEN1 phenocopy.Funding Information
- United Kingdom Medical Research Council (G1000467)
- Ipsen
- Wellcome Trust
- National Institute for Health Research
- NIHR Oxford Biomedical Research Centre
This publication has 33 references indexed in Scilit:
- Clinical MEN-1 Among a Large Cohort of Patients With AcromegalyJournal of Clinical Endocrinology & Metabolism, 2020
- MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patientsBMC Medicine, 2016
- ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary SiteNeuroendocrinology, 2016
- Frequent Large GermlineHRPT2Deletions in a French National Cohort of Patients With Primary HyperparathyroidismJournal of Clinical Endocrinology & Metabolism, 2013
- Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)Journal of Clinical Endocrinology & Metabolism, 2012
- Cdc73 Subunit of Paf1 Complex Contains C-terminal Ras-like Domain That Promotes Association of Paf1 Complex with ChromatinOnline Journal of Public Health Informatics, 2012
- Prevalence, characteristics and prognosis of MEN 1-associated glucagonomas, VIPomas, and somatostatinomas: Study from the GTE (Groupe des Tumeurs Endocrines) registryGastroentérologie Clinique et Biologique, 2004
- The glucagonoma syndrome and necrolytic migratory erythema: a clinical reviewActa Endocrinologica, 2004
- HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndromeNature Genetics, 2002
- A Genotypic and Histopathological Study of a Large Dutch Kindred with Hyperparathyroidism-Jaw Tumor Syndrome1Journal of Clinical Endocrinology & Metabolism, 2000